Spatial overlap of peptide hotspots and canonical drug pockets in a model enzyme. From molecular display peptides to small molecule inhibitors.
|
|
- Rachel Arnold
- 5 years ago
- Views:
Transcription
1 partnerships in biologics discovery Spatial overlap of peptide hotspots and canonical drug pockets in a model enzyme Walraj S. Gosal June 205 From molecular display peptides to small molecule inhibitors. In collaboration with: With funding from:
2 Display technology is pivotal for biologics discovery Humira (monoclonal antibody) is the biggest selling drug worldwide ($3bn in sales). Primary seq. 00 amino acid protein = x0 30 sequences Humira FAB Approved: RA, UC, CD fold into precise 3D structures TNFα" chemical reactions of life through the precise arrangement & dynamics of atoms Computational approaches are showing evermore promise (e.g. Rosetta),2. Design Crystal structure Kuhlman,B. et al. Science (2003). 2 Fleishman,S.J. et al. Science (20). 2
3 Display technology is pivotal for the emergence of biologics Recent emergence of over a dozen scaffolds ranging in size (~ 20 to 70 amino acids),2. Humira FAB DARPin Approved: RA, UC, CD TNFα" Anticalin e.g. PRS-050 (Phase I: angiogenesis) e.g. Abicipar pegol (Phase III: macular degeneration) Adnectin / Centyrin e.g. Angiocept (phase II glioblastoma) Affibody e.g. SOBI002 (Phase I: inflammation) Knottin e.g. Ziconotide (Approved: pain relief) Lofblom,J. et al. Current Opinion in Biotechnology (20). 2 Gronwall, C. et al. Journal of Biotechnology (2009).
4 pept random library Display technology is pivotal for biologics discovery Basic idea is to enrich phenotypes in a library and be able to read genotypes. CIS Display2-4 First described by George Smith in 985 using bacterial filamentous phage (phage display). Incubation with PCR amplification of binders random library random library Smith,G.P. 4Patel,S. random library In vitro transcription & translation Science (985). 2Odegrip,R. et al. PNAS (2004).3Eldridge,B. et al. Protein Eng. Des. Eng. (2009). et al. Protein Eng. Des. Eng. (203). 4
5 CIS display & NGS random peptide library selection, amplifiction & NGS. CIS display & NGS Protein VLSEGEWQLVLHVWAKVEADV peptide site I 05 AQGAMNKALELFRKDIAAKYK site II peptide Residue hotspots & field calculation 3. Structure determination Computation (mutational analysis, Rosetta, & XED force field) (NMR or X-ray) VLSEGEWQLVLHVWAKVEADV 05 AQGAMNKALELFRKDIAAKYK site II h2 5. Virtual molecule (>07 small m -ve/hbd h3 Target-binding peptide candidates 2. Peptide hit validation (ELISA, truncation, binding, activity, epitope mapping) h & screening site I random peptide library Small&-binding peptides 4. selection, amplifiction NGS 2. Peptide hit validation (ELISA, truncation, binding, activity, epitope mapping). CIS display & NGS Target-binding peptide candidates rget X-ray / NMR Can molecular display be used to inform small molecule discovery? VdW surface h4 +ve/hba hydrophobic Small -binding peptides 3. Structure determination (NMR or X-ray) Peptide field map 6. Focused experimental screen O H N NH O H N OH O
6 Target of choice: thrombin - a serine protease 40 year race in the drug industry to replace anticoagulants - Warfarin (953) & Heparin (937),2. Large body of public information that covers all major discovery platforms (fragment screening, structurebased design & HTS). S S S S2 S4 S2 S4 S2 S4 Substrate: FPA Dabigatran Melagatran Unique structure based solutions from Nature 3. s-variegin 3 (32 aa) Tropical bont tick Anophelin 3 (3 aa) Mosquito Hirudin 3 (65aa) Medicinal leech Gustafsson,D. Nature Reviews Drug Discovery (2004). 2 Nar, H. Trends in Pharm. Sci (202). 3 Huntington, J. A. Thromb. Haemost., (204). 6
7 Summary & Acknowledgements. In a retrospective study, CIS display peptide hot-spots spatially overlap with known drug pockets in thrombin, although novel pockets are induced. 2. Peptides cover the chemical solution space for the primary S pocket. 3. Field patterns based on peptides can be used to find new inhibitors. Chris Ullman Neil Cooley Kevin Matthews Gabriela Ivanova Amanda Hallott Shabana Vohra Contact Walraj S. Gosal walraj.gosal@isogenica.com Steve Gardner Dirk Gewert Peter Campbell Robert Scoffin Andy Vinter Mark Mackey Gordon Woodrow Stephan Krapp Tom Blundell Jim Huntington Ty Adams With funding from: 7
A New Peptide Drug Modality; Helix-Loop-Helix Technology. Interprotein Corporation
A New Peptide Drug Modality; Helix-Loop-Helix Technology Interprotein Corporation 1 Interprotein Corporation Location: Osaka, Japan Year Established: 2001 CEO & President: Masato Hosoda www.interprotein.com
More informationX ray structure data Molecular dynamics simulation Sequence homology Educated guessing. Rational. Protein design
Biocatalyst Design Rational X ray structure data Molecular dynamics simulation Sequence homology Educated guessing Protein design Random Do enough mistakes, so many time you are bound to get it right some
More informationRecent Progress of Interprotein s Research Activities. Interprotein Corporation
Recent Progress of Interprotein s Research Activities - INTENDD and AI-guided INTENDD - Interprotein Corporation 1 Interprotein Corporation Location: Osaka, Japan Year Established: 2001 CEO & President:
More informationAntibodies to Challenging Receptor Targets through NGS and Cell-Based Antibody Phage Panning. Mark Tornetta
Antibodies to Challenging Receptor Targets through NGS and Cell-Based Antibody Phage Panning Mark Tornetta Points to convey regarding receptor targets Antigen diversity- cells and engineered ECDs Be creative
More informationAffinity Reagents: The Landscape and Affimer Technology Competitive Advantages
Affinity Reagents: The Landscape and Affimer Technology Competitive Advantages Introduction It is well accepted that the limitations of antibodies present valuable commercial opportunities for alternative
More informationNext-generation analysis of deep sequencing data: Bringing light into the black box of phage display experiments
Next-generation analysis of deep sequencing data: Bringing light into the black box of phage display experiments Dr. Michael Blank (CSO, AptaIT) Biologics 2015; Berlin 02-03 February 1 Accelerating in
More informationSelf-financed Coursework Advanced Workshop on Molecular Docking, Virtual Screening & Computational Biology 13 th - 15 th March 2019
Self-financed Coursework Advanced Workshop on Molecular Docking, Virtual Screening & Computational Biology 13 th - 15 th March 2019 Indian Institute of Information Technology- Allahabad Jhalwa Campus,
More informationComparative Modeling Part 1. Jaroslaw Pillardy Computational Biology Service Unit Cornell Theory Center
Comparative Modeling Part 1 Jaroslaw Pillardy Computational Biology Service Unit Cornell Theory Center Function is the most important feature of a protein Function is related to structure Structure is
More informationModule 2 overview SPRING BREAK
1 Module 2 overview lecture lab 1. Introduction to the module 1. Start-up protein eng. 2. Rational protein design 2. Site-directed mutagenesis 3. Fluorescence and sensors 3. DNA amplification 4. Protein
More informationIdentifying the antibody specificity repertoire
Identifying the antibody specificity repertoire Rafael Smith, Joel Bozekowski, Michael Paul, Patrick Daugherty Department of Chemical Engineering Daugherty Group Gorman Scholar You have a unique antibody
More informationAntibody Discovery at Evotec
Antibody Discovery at Evotec - Overview - Evotec Antibodies Adding value to our partners research Innovative and flexible solutions from target ID to pre-clinical candidate The people A wide therapeutic
More informationHow Targets Are Chosen. Chris Wayman 12 th April 2012
How Targets Are Chosen Chris Wayman 12 th April 2012 A few questions How many ideas does it take to make a medicine? 10 20 20-50 50-100 A few questions How long does it take to bring a product from bench
More informationContents... vii. List of Figures... xii. List of Tables... xiv. Abbreviatons... xv. Summary... xvii. 1. Introduction In vitro evolution...
vii Contents Contents... vii List of Figures... xii List of Tables... xiv Abbreviatons... xv Summary... xvii 1. Introduction...1 1.1 In vitro evolution... 1 1.2 Phage Display Technology... 3 1.3 Cell surface
More informationCOMPAS for the Analysis of SELEX Experiments
COMPAS for the Analysis of SELEX Experiments COMPAS (COMmon PAtternS) is a software tool that was especially developed to harness the technology of next generation sequencing (NGS) to bring light into
More informationPrediction of Protein-Protein Binding Sites and Epitope Mapping. Copyright 2017 Chemical Computing Group ULC All Rights Reserved.
Prediction of Protein-Protein Binding Sites and Epitope Mapping Epitope Mapping Antibodies interact with antigens at epitopes Epitope is collection residues on antigen Continuous (sequence) or non-continuous
More informationProCode TM. Life Science, Inc. A Rapid Flexible MAb-Like Discovery Platform for Creating Diagnostic Antibodies.
ProCode TM A Rapid Flexible MAb-Like Discovery Platform for Creating Diagnostic Antibodies Life Science, Inc. www.meridianlifescience.com Custom Monoclonal Development Meridian Life Science, Inc. (MLS)
More informationReal World Drug Discovery A Chemist's Guide to Biotech and Pharmaceutical Research
Real World Drug Discovery A Chemist's Guide to Biotech and Pharmaceutical Research Robert M. Rydzewski ELSEVIER Amsterdam Boston Heidelberg London New York Oxford Paris San Diego San Francisco Singapore
More informationPeptide libraries: applications, design options and considerations. Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST
Peptide libraries: applications, design options and considerations Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST Overview 1 2 3 4 5 Introduction Peptide library basics Peptide library design considerations
More informationNature inspired design of motif specific antibody scaffolds *
Nature inspired design of motif specific antibody scaffolds * Nature Biotechnology, October 2013, Vol. 31, #10 * Scientific information in the following slides is from this article, if not stated otherwise
More informationProtein isotopic enrichment for NMR studies
Protein isotopic enrichment for NMR studies Protein NMR studies ARTGKYVDES sequence structure Structure of protein- ligand, protein-protein complexes Binding of molecules (perturbation mapping) Dynamic
More informationDNA Matters Constructing Genes, Enzymes and Pathways by the Plate
DNA Matters Constructing Genes, Enzymes and Pathways by the Plate Leda Notchey May 19, 2015 Agenda 1. The Synthetic Biology Opportunity 2. The Gen9 Advantage 3. Working with Gen9: o o Custom Gene Synthesis
More informationProtein design. CS/CME/BioE/Biophys/BMI 279 Oct. 24, 2017 Ron Dror
Protein design CS/CME/BioE/Biophys/BMI 279 Oct. 24, 2017 Ron Dror 1 Outline Why design proteins? Overall approach: Simplifying the protein design problem < this step is really key! Protein design methodology
More informationDrug Discovery Targeting the GHKL Superfamily - HSP90, DNA Gyrase, Histidine Kinases
Drug Discovery Targeting the GHKL Superfamily - HSP90, DNA Gyrase, Histidine Kinases (Jason) Xinshan Kang, Boris Klebansky, Richard Fine BioPredict, Inc., 660 KinderKamack Rd., radell, NJ 07649 232 nd
More informationDrug Targets - an overview of historical success and protein kinase inhibitors - successes and attrition. John P. Overington
Drug Targets - an overview of historical success and protein kinase inhibitors - successes and attrition John P. Overington jpo@ebi.ac.uk Assay/Target ChEMBL The Organisation of Drug Discovery 1. Scientific
More informationModule 2 overview SPRING BREAK
1 Module 2 overview lecture lab 1. Introduction to the module 1. Start-up protein eng. 2. Rational protein design 2. Site-directed mutagenesis 3. Fluorescence and sensors 3. DNA amplification 4. Protein
More informationCourse Agenda. Day One
Course Agenda BioImmersion: Biotech for the Non-Scientist A three-day, in-depth course that provides the background required for understanding today s fast-paced biotech marketplace. Beginning with an
More informationExam MOL3007 Functional Genomics
Faculty of Medicine Department of Cancer Research and Molecular Medicine Exam MOL3007 Functional Genomics Tuesday May 29 th 9.00-13.00 ECTS credits: 7.5 Number of pages (included front-page): 5 Supporting
More informationTAPBOOST. Breakthrough Platform to Improve Protein Production
Breakthrough Platform to Improve Protein Production Protein Folding System and Quality Control System Protein Folding RNA Polypeptide Misfolded Protein Cell Quality Control System Degradation of proteins
More informationDigital Display Libraries using High Density Peptide Arrays Max Bergmann Konferenz XXXVI
Digital Display Libraries using High Density Peptide Arrays Max Bergmann Konferenz XXXVI - 2015 Klaus-Peter Stengele, Jigar Patel Roche NimbleGen Inc, Madison, WI www.nimblegen.com Roche NimbleGen Peptide
More informationIntroduction to Drug Design and Discovery
Introduction to Drug Design and Discovery Course: Drug Design Course code: 0510412 Dr. Balakumar Chandrasekaran Dr. Bilal Al-Jaidi Assistant Professors, Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy,
More informationChapter 8 DNA Recognition in Prokaryotes by Helix-Turn-Helix Motifs
Chapter 8 DNA Recognition in Prokaryotes by Helix-Turn-Helix Motifs 1. Helix-turn-helix proteins 2. Zinc finger proteins 3. Leucine zipper proteins 4. Beta-scaffold factors 5. Others λ-repressor AND CRO
More informationB. Incorrect! Ligation is also a necessary step for cloning.
Genetics - Problem Drill 15: The Techniques in Molecular Genetics No. 1 of 10 1. Which of the following is not part of the normal process of cloning recombinant DNA in bacteria? (A) Restriction endonuclease
More information" Rational drug design; a Structural Genomics approach"
" Rational drug design; a Structural Genomics approach" Meeting the need of time; Dr Sanjan K. Das, PhD. Chief Scientific Officer (CSO), BBUK. Institute of Cancer Therapeutics University of Bradford, UK.
More informationQIAGEN s NGS Solutions for Biomarkers NGS & Bioinformatics team QIAGEN (Suzhou) Translational Medicine Co.,Ltd
QIAGEN s NGS Solutions for Biomarkers NGS & Bioinformatics team QIAGEN (Suzhou) Translational Medicine Co.,Ltd 1 Our current NGS & Bioinformatics Platform 2 Our NGS workflow and applications 3 QIAGEN s
More informationClamping down on pathogenic bacteria how to shut down a key DNA polymerase complex
Clamping down on pathogenic bacteria how to shut down a key DNA polymerase complex Bacterial DNA-replication machinery Pathogenic bacteria that are resistant to the current armoury of antibiotics are an
More informationHow to Screen a Billion Drug Candidates?
How to Screen a Billion Drug Candidates? Single Cell Functional Assays: Ultra-sensitive, Ultra-fast, Ultrahigh-throughput Next-Generation Drug Discovery The advantages of de novo protein engineering for
More informationCombinatorial RNA libraries
SELEX and Artificial Ribozymes Some definitions SELEX: Systematic Evolution of Ligands by EXponential Enrichment (alternatively: in vitro selection, in vitro evolution) Aptamer: nucleic acid ligand (from
More informationBlotting Techniques (Southern blot, Northern blot, Western blot, and Eastern blot)
Blotting Techniques (Southern blot, Northern blot, Western blot, and Eastern blot) Masheal Aljumaah SEP 2018 Learning Objectives: What is blotting? Blotting Techniques Types. Applications for each technique.
More informationModule I: Introduction
Module I: Introduction 20.109 Lecture 1 3 February, 2011 Introduction to: Module Overview Fundamental concepts and techniques in molecular biology Appreciating nucleic acids (RNA in particular) as more
More informationWhy do LC MS and LBA
Why do LC MS and LBA results differ? A literature evaluation 18 November 2015 Nico van de Merbel An overview In most published BA methods for large molecules, no comparison of platforms (LBA vs LBA, LBA
More informationCustom Antibody Services. Antibodies Designed Just for You. HuCAL Recombinant Monoclonal Antibody Generation Service
Custom Antibody Services Antibodies Designed Just for You HuCAL Recombinant Monoclonal Antibody Generation Service Antibodies Designed Just for You What if there was a technology that would allow you to
More informationSCREENING AND PRESERVATION OF DNA LIBRARIES
MODULE 4 LECTURE 5 SCREENING AND PRESERVATION OF DNA LIBRARIES 4-5.1. Introduction Library screening is the process of identification of the clones carrying the gene of interest. Screening relies on a
More informationProtein design. CS/CME/BioE/Biophys/BMI 279 Oct. 24, 2017 Ron Dror
Protein design CS/CME/BioE/Biophys/BMI 279 Oct. 24, 2017 Ron Dror 1 Outline Why design proteins? Overall approach: Simplifying the protein design problem Protein design methodology Designing the backbone
More informationInnovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing
Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing Overview Serving biotech and pharma community since 1998 Proven track record of advancing small molecules from
More information11/22/13. Proteomics, functional genomics, and systems biology. Biosciences 741: Genomics Fall, 2013 Week 11
Proteomics, functional genomics, and systems biology Biosciences 741: Genomics Fall, 2013 Week 11 1 Figure 6.1 The future of genomics Functional Genomics The field of functional genomics represents the
More informationSelected Techniques Part I
1 Selected Techniques Part I Gel Electrophoresis Can be both qualitative and quantitative Qualitative About what size is the fragment? How many fragments are present? Is there in insert or not? Quantitative
More informationNew Product: X-Aptamer Selection Kit. Updated April 2015
New Product: X-Aptamer Selection Kit Updated April 2015 Technology Basics X-Aptamers are synthetic affinity molecules Similar in function to monoclonal antibodies X-Aptamers combine a variety of chemical
More informationExpressive. Bacterial surface display for the identification of active ingredients for the pharmaceutical and cosmetics industry
Active Ingredient Research Expressive Bacterial surface display for the identification of active ingredients for the pharmaceutical and cosmetics industry Prof. Dr. Joachim Jose, Institute of Pharmaceutical
More informationProtein design. CS/CME/Biophys/BMI 279 Oct. 20 and 22, 2015 Ron Dror
Protein design CS/CME/Biophys/BMI 279 Oct. 20 and 22, 2015 Ron Dror 1 Optional reading on course website From cs279.stanford.edu These reading materials are optional. They are intended to (1) help answer
More informationExam MOL3007 Functional Genomics
Faculty of Medicine Department of Cancer Research and Molecular Medicine Exam MOL3007 Functional Genomics Thursday December 20 th 9.00-13.00 ECTS credits: 7.5 Number of pages (included front-page): 5 Supporting
More informationAntibody-Antigen recognition. Structural Biology Weekend Seminar Annegret Kramer
Antibody-Antigen recognition Structural Biology Weekend Seminar 10.07.2005 Annegret Kramer Contents Function and structure of antibodies Features of antibody-antigen interfaces Examples of antibody-antigen
More informationUsing a BioCel System and AssayMap Technology in Phage Display and Antibody Screening. Jason Graves September 20, 2011 AAS User Group Meeting
Using a BioCel System and AssayMap Technology in Phage Display and Antibody Screening Jason Graves September 20, 2011 AAS User Group Meeting My Background 15 Years of Automation and Related Experience
More informationProteoGenix. Life Sciences Services and Products. From gene to biotherapeutics Target Validation to Lead optimisation
ProteoGenix Life Sciences Services and Products From gene to biotherapeutics Target Validation to Lead optimisation ProteoGenix Philippe FUNFROCK, founder and CEO French company located in Strasbourg,
More informationChapter 17. Prediction, Engineering, and Design of Protein Structures
Chapter 17. Prediction, Engineering, and Design of Protein Structures Homologous proteins have similar structure and function Branden & Tooze (1998), Introduction to protein structure, 2 nd ed., p.349.
More informationEvolutionary Methods in B iotechnology
Evolutionary Methods in B iotechnology Clever Tricks for Directed Evolution Susanne Brakmann I Andreas Schwienhorst 1 Introduction Susanne Brakmann and Andreas Schwienhorst 1 References 3 2 Generation
More information3D Structure of Biologics in a Convenient Immunoassay Format
3D Structure of Biologics in a Convenient Immunoassay Format Xing Wang, Ph.D. Array Bridge Inc. 5/25/2017 1 Topics Covered Today Why New Technologies? Technology Development. Case Studies for Novel and
More informationSynthetic Biology. Sustainable Energy. Therapeutics Industrial Enzymes. Agriculture. Accelerating Discoveries, Expanding Possibilities. Design.
Synthetic Biology Accelerating Discoveries, Expanding Possibilities Sustainable Energy Therapeutics Industrial Enzymes Agriculture Design Build Generate Solutions to Advance Synthetic Biology Research
More informationApplication Note AN001
Testing hybridoma supernatants with the Spots On Dots Antibody Screening Kit Application Note AN1 Table of Contents Overview... 2 Figure 1. Screening of hybridomas raised against peptide antigens... 3
More informationOpportunities for Accelerating Cell Line Development and Beyond
Opportunities for Accelerating Cell Line Development and Beyond European CM&C Strategy Forum May 24, 2017 Christopher Frye, Ph.D. Research Advisor & Group Leader Bioprocess R&D Presentation Outline CM&C
More informationHomology Modelling. Thomas Holberg Blicher NNF Center for Protein Research University of Copenhagen
Homology Modelling Thomas Holberg Blicher NNF Center for Protein Research University of Copenhagen Why are Protein Structures so Interesting? They provide a detailed picture of interesting biological features,
More informationSupplementary Information. Human Antibody-Based Chemically Induced Dimerizers for Cell Therapeutic Applications
Supplementary Information Human Antibody-Based Chemically Induced Dimerizers for Cell Therapeutic Applications Zachary B Hill 1,4, Alexander J Martinko 1,2,4, Duy P Nguyen 1 & James A Wells *1,3 1 Department
More informationPosition1: Senior Scientist/Principal Scientist
Position1: Senior Scientist/Principal Scientist Field: Immunology, Immuno-Oncology Department: Discovery Biology : o Develop and conduct cell or immune based assays to support drug discovery in cancer
More informationBIRKBECK COLLEGE (University of London)
BIRKBECK COLLEGE (University of London) SCHOOL OF BIOLOGICAL SCIENCES M.Sc. EXAMINATION FOR INTERNAL STUDENTS ON: Postgraduate Certificate in Principles of Protein Structure MSc Structural Molecular Biology
More informationCompound Re-Profiling. Dr Robert Scoffin CEO, Cresset
Compound Re-Profiling Dr Robert Scoffin CEO, Cresset What is it? F F F N N H 2 N S O O Br > Compound Re-Profiling or Re-Purposing is the process of finding a new clinical use for an existing treatment
More informationTranslation BIT 220 Chapter 13
Translation BIT 220 Chapter 13 Making protein from mrna Most genes encode for proteins -some make RNA as end product Proteins -Monomer Amino Acid 20 amino acids -peptides -polypeptides -Structure of Amino
More informationTools and Technologies for Immunogenicity and Allergenicity Risk Management
Tools and Technologies for Immunogenicity and Allergenicity Risk Management Dr. Jeremy Fry HESI PATC Symposium on Sensitizing Properties of Proteins 11-13 April 2012 Immunogenicity and Allergenicity Immunogenicity
More informationPhage Display. Tim Clackson ARIAD Pharmaceuticals Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA Henry B. Lowman OXFORD UNIVERSITY PRESS
Phage Display Edited by Tim Clackson ARIAD Pharmaceuticals Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA Henry B. Lowman Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA OXFORD UNIVERSITY
More informationIn Silico DNA-Based Aptamer Selection and Construction
In Silico DNA-Based Aptamer Selection and Construction Pete Gannett June 18, 2014 HPC pgannett@hsc.wvu.edu 304.293.1480 (ofc) Outline Introduction to Aptamers 1-D aptamer selection 2-D and 3-D aptamer
More informationThe Two-Hybrid System
Encyclopedic Reference of Genomics and Proteomics in Molecular Medicine The Two-Hybrid System Carolina Vollert & Peter Uetz Institut für Genetik Forschungszentrum Karlsruhe PO Box 3640 D-76021 Karlsruhe
More informationCall for Pilot Project Applications Chemical Biology for Infectious Diseases NIH Center of Biomedical Research Excellence University of Kansas
Call for Pilot Project Applications Chemical Biology for Infectious Diseases NIH Center of Biomedical Research Excellence University of Kansas Applications due: Oct 3 rd, 2016 Anticipated Decision Date:
More informationPharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001
Pharmacogenetics: A SNPshot of the Future Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 1 I. What is pharmacogenetics? It is the study of how genetic variation affects drug response
More informationAdvanced Therapeutic Antibody Discovery with Multiplexed Screening
Advanced Therapeutic Antibody Discovery with Multiplexed Screening White Paper Scientists need powerful tools that can deliver results to fully understand the ability of candidate antibodies to interrupt
More informationPioneering Clinical Omics
Pioneering Clinical Omics Clinical Genomics Strand NGS An analysis tool for data generated by cutting-edge Next Generation Sequencing(NGS) instruments. Strand NGS enables read alignment and analysis of
More informationTherapeutic Proteins BIT 230
Therapeutic Proteins BIT 230 CLOTTING Haemophilia Benefix Blood Products ANTICOAGULANT THROMBOLYTIC AGENTS tissue plasminogen activator streptokinase Coagulation pathway Factor VIII (Haemophilia A) Factor
More informationSample Question Paper Session Class XII Biotechnology (045) Marking Scheme
Sample Question Paper Session 2015-16 Class XII Biotechnology (045) Marking Scheme SECTION-A 1. Methylation Student will add a methyl group to one or two bases within the sequence recognized by enzyme.
More informationEnzyme that uses RNA as a template to synthesize a complementary DNA
Biology 105: Introduction to Genetics PRACTICE FINAL EXAM 2006 Part I: Definitions Homology: Comparison of two or more protein or DNA sequence to ascertain similarities in sequences. If two genes have
More informationResearch in Structural Bioinformatics and Molecular Biophysics. OUTLINE: What is it and why is it useful? EXAMPLES: b. Improving enzyme s function.
Research in Structural Bioinformatics and Molecular Biophysics OUTLINE: What is it and why is it useful? EXAMPLES: a. Biomolecular surface story. b. Improving enzyme s function. c. Folding proteins. Alexey
More informationImmunogenicity: Assessing the Clinical Relevance and Risk Minimization of Antibodies to Biopharmaceuticals
Immunogenicity: Assessing the Clinical Relevance and Risk Minimization of Antibodies to Biopharmaceuticals Daniel Kramer/Kathleen Beach Need for public-private collaboration 1 All biopharmaceuticals are
More informationCurrent Research. Examples of current research projects:
Current Research Dr Richard Foster Medicinal Chemistry and Chemical Biology Group Leader Medicinal Chemistry Tutor School of Chemistry University of Leeds r.foster@leeds.ac.uk +44 (0)1133435759 Our group
More informationApplying Affimers. Dr Amanda Nicholl at Avacta Life Sciences. Improving Antibody PK Assay Development
Improving Pharmacokinetic Assays in a Regulatory Bioanalysis Setting Applying Affimers With an increasing number of antibody-based therapeutics entering the clinic, the need for validated anti-idiotypic
More informationIn vitro mutagenesis
Core course BMS361N Genetic Engineering In vitro mutagenesis Prof. Narkunaraja Shanmugam Dept. Of Biomedical Science School of Basic Medical Sciences Bharathidasan University In vitro mutagenesis Many
More informationThe Biotechnology Toolbox
Chapter 15 The Biotechnology Toolbox Cutting and Pasting DNA Cutting DNA Restriction endonuclease or restriction enzymes Cellular protection mechanism for infected foreign DNA Recognition and cutting specific
More informationBuilding DNA Libraries to Explore the Combinatorial Design Space. Dr. Yifan Li Senior Scientist GenScript USA Inc.
Building DNA Libraries to Explore the Combinatorial Design Space Dr. Yifan Li Senior Scientist GenScript USA Inc. Outline Combinatorial Optimization for Metabolic Pathway Engineering Case Studies for Combinatorial
More informationEnabling Lead Discovery at Epigenetics Targets with RapidFire Mass Spectrometry
Enabling Lead Discovery at Epigenetics Targets with RapidFire Mass Spectrometry Stuart Baddeley Director, Screening and Compound Profiling GlaxoSmithKline R&D Stevenage, UK Overview 1. Introduction to
More informationRecombinational cloning Cell-free protein synthesis system
Dr. Sanjeeva Srivastava IIT Bombay Recombinational cloning Cell-free protein synthesis system IIT Bombay 2 1 IIT Bombay 3 A novel site-specific recombination technique to transfer DNA sequences universal
More informationFig. 1. A schematic illustration of pipeline from gene to drug : integration of virtual and real experiments.
1 Integration of Structure-Based Drug Design and SPR Biosensor Technology in Discovery of New Lead Compounds Alexis S. Ivanov Institute of Biomedical Chemistry RAMS, 10, Pogodinskaya str., Moscow, 119121,
More informationPlantForm Corporation
PlantForm Corporation Annual General Meeting September 21, 2010 Dr. Don Stewart President and CEO +1 (416) 452 7242 don.stewart@plantformcorp.com PlantForm Corporation 2010 www.plantformcorp.com The Opportunity
More informationOncology Product and Platform Partnering Opportunity
Protein Medicinal Chemistry with an Expanded Genetic Code Oncology Product and Platform Partnering Opportunity April 2017 Ambrx has Made Advances in Proprietary Platform and Titer while Achieving Clinical
More informationModule Overview. Lecture
Module verview Day 1 2 3 4 5 6 7 8 Lecture Introduction SELEX I: Building a Library SELEX II: Selecting RNA with target functionality SELEX III: Technical advances & problem-solving Characterizing aptamers
More informationParallel analysis of translated ORF (PLATO)
Parallel analysis of translated ORF (PLATO) Technical Journal Club 16.04.2013 Mary-Aude Rochat, PhD student Speck group Proteomics Rationale: Increase in the DNA sequence information Understand biological
More informationMeet the CEO developing the Next Generation of Antibody Therapeutics
Meet the CEO developing the Next Generation of Antibody Therapeutics Written by Evelyn Warner Editor in Chief, Labiotech.eu Crescendo Biologics has positioned itself as the successor of Cambridge Antibody
More informationStrategic Collaboration with Amgen to develop MP0310
Strategic Collaboration with Amgen to develop MP0310 Patrick Amstutz, CEO Webcast of Molecular Partners AG, Switzerland (SIX: MOLN) December 19, 2018 2018 Molecular Partners AG Slide 1 Molecular Partners:
More informationCHAPTER 4. Milestones of the drug discovery
CHAPTER 4 Milestones of the drug discovery 4.Milestones of the drug discovery: Highlights the importance of the below critical milestones of the drug discovery and correlated to the current research. 1.
More informationThe Kinase Knowledgebase
The Kinase Knowledgebase Kevin P. Hambly Product Manager Derek A. Debe, Ph.D. Chief Scientific Officer Outline About Eidogen-Sertanty Kinase Knowledgebase Overview Content Curation Process Data Structure
More informationLaboratory Testing Issues for Protein C, Protein S and Antithrombin Assays
Laboratory Testing Issues for Protein C, Protein S and Antithrombin Assays Richard A. Marlar Ph.D. University of Oklahoma THSNA Meeting- Chicago, IL April 14-16, 2016 DISCLOSURE Richard A. Marlar, PhD
More informationPersonalized CAR-T Immunotherapy Platform
GLP, GMP, and CLIA-Certified Lab Personalized CAR-T Immunotherapy Platform Accelerate your cancer research and drug discovery Platform Overview 1500 Existing Hybridomas and Antibody Engineering Custom
More informationStructure of a novel phosphotyrosine-binding domain in Hakai that targets E-cadherin
Manuscript EMBO-2011-79235 Structure of a novel phosphotyrosine-binding domain in Hakai that targets E-cadherin Manjeet Mukherjee, Soah Yee Chow, Permeen Yusoff, Jayaraman Seetharaman, Cherlyn Ng, Saravanan
More informationHong Kong Pharmacy Conference Feb 2017 WHAT S IN A NAME NOMENCLATURE OF MONOCLONAL ANTIBODIES
Hong Kong Pharmacy Conference Feb 2017 WHAT S IN A NAME NOMENCLATURE OF MONOCLONAL ANTIBODIES Things you get after 20 mins: 1. How drugs are named 2. Monoclonal antibodies (mab) as an example: A. How to
More informationHuman Factor V ELISA Kit
Human Factor V ELISA Kit Catalog No: IRAPKT103 Lot No: SAMPLE INTRODUCTION Factor V (FV) is an essential cofactor of the blood coagulation cascade and circulates in plasma as a large single-chain glycoprotein.
More informationComputational Drug Design
Computational Drug Design Univ.-Prof. Dr. Gerhard F. Ecker Pharmacoinformatics Research Group Department of Medicinal Chemistry, University of Vienna Althanstrasse 14, A-1090 Wien, Austria e-mail: gerhard.f.ecker@univie.ac.at;
More information